ESMO has released twenty-three new statements to address issues and concerns on immunising patients with cancer against COVID-19.
The ESMO-CoCARE Registry is an international collaborative initiative, a cross-tumour database to quickly gather epidemiological, demographic, cancer-and COVID-19-related data specifically focusing on the impact of SARS-CoV-2 on cancer patients.
Designed to assist patients, relatives and caregivers to better understand how the pandemic can affect cancer care, how to lower the risk of becoming infected and other useful information.
These recommendations aim to develop guidance to mitigate the negative effects of the COVID-19 pandemic on the diagnosis and treatment of cancer patients.
Accompanied by an ESMO Patient Guide, available in different languages.
News On COVID-19 And Cancer
ESMO is making available a list of material released on the COVID-19 emergency on social media, but no content provided at these links is either proprietory of or endorsed by ESMO.